Clinical Trials Browser

Phase 2 × N-dihydrogalactochitosan × Clear all

NCT06526338 2025-09-30

Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular